Pharmacology and pharmacotherapy of cardiovascular drugs in patients with chronic renal disease
| Autor: | Marilyn M. Barbour, David S. McKindley |
|---|---|
| Rok vydání: | 2001 |
| Předmět: |
Drug
business.industry media_common.quotation_subject Renal function Angiotensin-Converting Enzyme Inhibitors Cardiovascular Agents Disease Chronic renal disease Pharmacology urologic and male genital diseases medicine.disease Calcium Channel Blockers Comorbidity Angiotensin Receptor Antagonists Pharmacotherapy Pharmacokinetics Nephrology Cardiovascular Diseases medicine Humans Kidney Failure Chronic In patient Drug Interactions business media_common |
| Zdroj: | Seminars in nephrology. 21(1) |
| ISSN: | 0270-9295 |
| Popis: | Cardiovascular disease is a common comorbidity and a major cause of mortality in patients with chronic renal disease. Drug regimens in patients with cardiovascular disease are frequently complex and can be significantly affected by alterations in renal function. In addition, several cardiovascular drugs directly affect renal function and the management of patients with renal disease. This article reviews the impact of renal disease on the pharmacokinetics of cardiovascular drugs and identifies clinically important interactions between these and other drugs commonly used in the management of chronic renal disease. Several classes of cardiovascular drugs are also discussed in relationship to their differential effects on the management and progression of renal disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|